Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter: A Multicenter, Randomized, Controlled Clinical Trial (PARAT)
- PMID: 29599173
- PMCID: PMC7410651
- DOI: 10.3174/ajnr.A5619
Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter: A Multicenter, Randomized, Controlled Clinical Trial (PARAT)
Abstract
Background and purpose: Although flow diverters have been reported with favorable clinical and angiographic outcomes in various literatures, randomized trials determining their true effectiveness and safety are still in lack. The Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using the Tubridge Flow Diverter (PARAT) trial was designed to evaluate the safety and efficacy of the Tubridge flow diverter in the treatment of large or giant aneurysms in comparison with Enterprise stent-assisted coiling.
Materials and methods: This prospective, multicenter, randomized trial was conducted at 12 hospitals throughout China. Enrolled adults with unruptured large/giant intracranial aneurysms were randomly assigned (1:1) to receive either Enterprise stent-assisted coiling or Tubridge flow diverter implantation. The primary end point was complete occlusion at 6-month follow-up, while secondary end points included technical success, mortality, target vessel-related stroke, aneurysm bleeding, in-stent stenosis, parent artery occlusion, and the frequency of all adverse events.
Results: Among 185 enrolled subjects, 41 withdrew before procedure initiation. Overall, 82 subjects underwent Tubridge implantation, and 62 subjects were primarily treated with stent-assisted coiling. The results of 6-month follow-up imaging included complete occlusion rates of 75.34% versus 24.53% for the Tubridge and stent-assisted coiling groups, respectively, with a calculated common odds ratio of 9.4 (95% confidence interval, 4.14-21.38; P < .001). There was a higher, nonsignificant frequency of complications for Tubridge subjects. Multivariate analysis showed a decreased stroke rate at the primary investigational site, with a marginal P value (P = .051).
Conclusions: This trial showed an obviously higher rate of large and giant aneurysm obliteration with the Tubridge FD over Enterprise stent-assisted coiling. However, this higher obliteration rate came at the cost of a nonsignificantly higher rate of complications. Investigational site comparisons suggested that a learning curve for flow-diverter implantation should be recognized and factored into trial designs.
© 2018 by American Journal of Neuroradiology.
Similar articles
-
Parent artery reconstruction for large or giant cerebral aneurysms using a Tubridge flow diverter (PARAT): study protocol for a multicenter, randomized, controlled clinical trial.BMC Neurol. 2014 May 4;14:97. doi: 10.1186/1471-2377-14-97. BMC Neurol. 2014. PMID: 24885396 Free PMC article. Clinical Trial.
-
Intracranial Aneurysms Managed by Parent Artery Reconstruction Using Tubridge Flow Diverter study: 1-year outcomes.J Neurosurg. 2024 Jun 14;141(6):1697-1704. doi: 10.3171/2024.3.JNS232116. Print 2024 Dec 1. J Neurosurg. 2024. PMID: 38875716 Clinical Trial.
-
Intracranial aneurysms managed by parent artery reconstruction using Tubridge: Study protocol for a prospective, multicenter, post-market clinical trial.Interv Neuroradiol. 2021 Aug;27(4):490-496. doi: 10.1177/1591019920976233. Epub 2020 Nov 25. Interv Neuroradiol. 2021. PMID: 33236687 Free PMC article.
-
Tubridge Flow Diverter for the Treatment of Unruptured Dissecting Cerebral Aneurysms.World Neurosurg. 2023 Apr;172:e343-e348. doi: 10.1016/j.wneu.2023.01.024. Epub 2023 Jan 11. World Neurosurg. 2023. PMID: 36639100 Review.
-
A rare but morbid neurosurgical target: petrous aneurysms and their endovascular management in the stent/flow diverter era.J Neurointerv Surg. 2017 Apr;9(4):381-383. doi: 10.1136/neurintsurg-2016-012668. Epub 2016 Sep 26. J Neurointerv Surg. 2017. PMID: 27672098 Review.
Cited by
-
Bibliometric analysis of China's contribution to the knowledge system of cerebrovascular intervention.Chin Neurosurg J. 2021 Dec 19;7(1):50. doi: 10.1186/s41016-021-00264-y. Chin Neurosurg J. 2021. PMID: 34924032 Free PMC article.
-
Evaluating the Tubridge™ flow diverter for large cavernous carotid artery aneurysms.Chin Neurosurg J. 2020 Dec 1;6(1):36. doi: 10.1186/s41016-020-00215-z. Chin Neurosurg J. 2020. PMID: 33292725 Free PMC article.
-
Safety and efficacy of tirofiban in the endovascular treatment of intracranial aneurysms: a systematic evaluation and meta-analysis.Neurosurg Rev. 2025 Jan 28;48(1):91. doi: 10.1007/s10143-025-03208-7. Neurosurg Rev. 2025. PMID: 39871064
-
Assessment of Interrater Reliability and Accuracy of Cerebral Aneurysm Morphometry Using 3D Virtual Reality, 2D Digital Subtraction Angiography, and 3D Reconstruction: A Randomized Comparative Study.Brain Sci. 2024 Sep 26;14(10):968. doi: 10.3390/brainsci14100968. Brain Sci. 2024. PMID: 39451982 Free PMC article.
-
Coiling followed by staged flow diversion for large and giant intracranial aneurysms.Front Neurol. 2022 Dec 1;13:1024447. doi: 10.3389/fneur.2022.1024447. eCollection 2022. Front Neurol. 2022. PMID: 36530617 Free PMC article.
References
-
- Barrow DL, Alleyne C. Natural history of giant intracranial aneurysms and indications for intervention. Clin Neurosurg 1995;42:214–44 - PubMed
-
- Gonzalez NR, Duckwiler G, Jahan R, et al. . Challenges in the endovascular treatment of giant intracranial aneurysms. Neurosurgery 2008;62(6 Suppl 3):1324–35 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical